HFSA 24: HU6 in Patients with Obesity and HFpEF: The HuMAIN Trial
Radcliffe Cardiology Radcliffe Cardiology
9.01K subscribers
74 views
6

 Published On Premiered Oct 2, 2024

A Novel Controlled Metabolic Accelerator For The Treatment Of Obesity-related Heart Failure With Preserved Ejection Fraction: HuMAIN-HFpEF Trial

Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook:   / radcliffecardiology  
Follow us on X: https://x.com/radcliffeCARDIO

show more

Share/Embed